News

Results Demonstrate 87% Reduction in Infection Rate Patients at high risk for surgical site infection following cardiac implantable electronic device (CIED) implantation with TYRX, Inc.’s AIGISRx Antibacterial Envelope experienced...

Angel Medical Systems, Inc., a privately held medical device company developing technologies for continuous intracardiac ischemia monitoring and alerting, announced that it completed an initial closing of an aggregate $27.5 million financing....

ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation and other cardiovascular diseases, announced that the paper "Effect of Bucindolol (Gencaro) on Heart Failure Outcomes and...

Pediatric Solution Provides Optimal Support for Resuscitation of Children ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, announced that its new FDA-cleared OneStep™ Pediatric CPR Electrodes are...

BioControl Medical has announced that the pilot clinical study of its CardioFit® vagus nerve stimulation system has been recognized as seminal original research in the European Journal of Heart Failure. According to a recent editorial, “the...

CardioMEMS, Inc., an Atlanta-based medical technology company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, announced that it has been honored as the 2012 recipient...

Endosense, a pioneer and leader in contact-force sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has named Nicolas Marsault as its new chief financial officer....

System supports smarter and easier device follow-up for both clinicians and patients Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced the first implant of PARADYM RF in Canada...

Boehringer Ingelheim will present data from eight abstracts at the American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, from December 8 to 11, including the results from a new sub-analysis of RE-LY® and four other...

Biosign Technologies Inc. is very pleased to announce that it has received official notification from the U.S. Food & Drug Administration, confirming that the company's UFIT TEN-10, now branded the Biosign Pulsewave™ Monitor, has been...